Ross Ramsey
Family Medicine · Elkton, MINPI 1770712986
Payments from drug & device makers
Across 321 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$943
- AbbVie$693
- Lilly USA, LLC$500
- Boehringer Ingelheim$395
- Mylan Specialty L.p.$342
- Bayer$338
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,284100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 72 | $943 |
| AbbVie(2 entities) | 28 | $693 |
| Lilly USA, LLC | 36 | $500 |
| Boehringer Ingelheim | 23 | $395 |
| Mylan Specialty L.p. | 18 | $342 |
| Bayer | 19 | $338 |
| Johnson & Johnson | 23 | $315 |
| Amgen(2 entities) | 18 | $283 |
| AstraZeneca | 16 | $282 |
| Pfizer | 11 | $241 |
| Astellas Pharma US Inc | 9 | $136 |
| GSK | 7 | $111 |
| Esperion Therapeutics, Inc. | 5 | $94 |
| Amarin Pharma, Inc. | 6 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Stryker | 1 | $72 |
| Kowa Pharmaceuticals America, Inc. | 5 | $65 |
| Viatris Specialty LLC | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Novartis | 3 | $38 |
| Biohaven Pharmaceuticals, Inc. | 1 | $28 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Merck | 2 | $25 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Nalpropion Pharmaceuticals LLC | 1 | $12 |
How this compares
$5,284 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 127 | $143,225 |
| TrulicityDulaglutide | 56 | $82,175 |
| MounjaroTirzepatide | 51 | $79,478 |
| EliquisApixaban | 39 | $55,005 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $49,639 |
| Tresiba Flextouch U-200Insulin Degludec | 37 | $44,951 |
| OzempicSemaglutide | 17 | $38,215 |
| XareltoRivaroxaban | 34 | $38,000 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 23 | $37,490 |
| KerendiaFinerenone | 21 | $36,433 |
| MyrbetriqMirabegron | 28 | $30,455 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 32 | $24,886 |
| Xigduo XrDapaglifloz Propaned/Metformin | 22 | $24,207 |
| EntrestoSacubitril/Valsartan | 12 | $19,589 |
| Repatha SureclickEvolocumab | 20 | $18,289 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Stiolto Respimat | $395 | $205,600182 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $500 | $161,653107 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Shingrix | $111 | $66,80092 claims |
| Johnson & JohnsonXarelto, Invokana | $315 | $55,85845 claims |
| PfizerEliquis | $241 | $55,00539 claims |
| Novo NordiskOzempic | $943 | $38,21517 claims |
| BayerKerendia | $338 | $36,43321 claims |
| Astellas Pharma US IncMyrbetriq | $136 | $30,45528 claims |
| NovartisEntresto | $38 | $19,58912 claims |
| AstraZenecaFarxiga | $282 | $14,40214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Elkton
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.